637
Views
11
CrossRef citations to date
0
Altmetric
Review

Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy

&
Pages 429-438 | Received 10 Jul 2020, Accepted 14 Dec 2020, Published online: 28 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandro Rizzo, Angela Dalia Ricci & Giovanni Brandi. (2021) Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer. Expert Opinion on Investigational Drugs 30:4, pages 343-350.
Read now

Articles from other publishers (10)

Alessandra Caligiuri, Maurizio Parola, Fabio Marra, Stefania Cannito & Alessandra Gentilini. (2023) Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components. Hepatoma Research.
Crossref
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang & Nariman Nezami. (2023) Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 15:9, pages 2624.
Crossref
Xianzhe Yu, Lingling Zhu, Ting Wang & Jiang Chen. (2023) Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies. Frontiers in Immunology 14.
Crossref
Daoying Zhou, Zhen Duan, Zhenyu Li, Fangfang Ge, Ran Wei & Lingsuo Kong. (2022) The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment. Frontiers in Pharmacology 13.
Crossref
Fa-Peng Zhang, Ke Zhu, Tai-Feng Zhu, Chao-Qun Liu, Hong-Hua Zhang, Lei-Bo Xu, Gang Xiao & Chao Liu. (2022) Intra-Tumoral Secondary Follicle-like Tertiary Lymphoid Structures Are Associated with a Superior Prognosis of Overall Survival of Perihilar Cholangiocarcinoma. Cancers 14:24, pages 6107.
Crossref
Kai Zhao, Xiangyu Li, Yuanxin Shi, Yun Lu, Peng Qiu, Zhengdong Deng, Wei Yao & Jianming Wang. (2022) Exosomes in the tumor microenvironment of cholangiocarcinoma: current status and future perspectives. Journal of Translational Medicine 20:1.
Crossref
Yiyu Qin, Mingdi Zhang, Haiming Lei, Hongyan Wu, Cheng Huang, Xin Zhou, Yang Fu, Mingzhe Weng & Mingzhe Ma. (2022) Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment. Drug Development Research 83:8, pages 1831-1844.
Crossref
Yuan Tian, Cheng Cheng, Yuchong Wei, Fang Yang & Guiying Li. (2022) The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation. Cells 11:6, pages 1005.
Crossref
Canghai Guan, Lang Liu, Yuqiao Zhao, Xianhe Zhang, Guanglin Liu, Haicun Wang, Xin Gao, Xiangyu Zhong & Xingming Jiang. (2021) YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1. Aging 13:23, pages 25195-25212.
Crossref
E. Kenneth Parkinson, Jerzy Adamski, Grit Zahn, Andreas Gaumann, Fabian Flores-Borja, Christine Ziegler & Maria E. Mycielska. (2021) Extracellular citrate and metabolic adaptations of cancer cells. Cancer and Metastasis Reviews 40:4, pages 1073-1091.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.